EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

SARS-CoV-2 Infection and Adverse Maternal and Perinatal Outcomes: Time-to-Event Analysis of a Hospital-Based Cohort Study of Pregnant Women in Rio de Janeiro, Brazil

Michelle Brendolin iD, Mayumi Duarte Wakimoto iD, Raquel de Vasconcellos Carvalhaes de Oliveira iD, Larissa Rangel Mageste, Karin Nielsen-Saines iD, Patricia Brasil iD

Viruses · 2025

DOI: 10.3390/v17020207 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Viruses, 2025. Verfasst von Michelle Brendolin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Maternity Department, Adão Pereira Nunes Hospital, Duque de Caxias 25.211-970, Brazil. Hauptthemen laut MEDLINE: COVID-19, Pregnancy Complications, Infectious. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding perinatal health outcomes following SARS-CoV-2 infection during pregnancy necessitates large-scale studies of mother-infant dyads. Hospital-based studies of pregnant women and their neonates provide valuable insights within the field of perinatal health research. The aim of this study was to evaluate the effect of SARS-CoV-2 infection on maternal and perinatal outcomes among hospitalized pregnant women in Rio de Janeiro during the COVID-19 pandemic.

Methods

The study consisted of a time-to-event analysis of a hospital-based cohort of 1185 pregnant women ≥ 16 years and their infants from May 2020 to March 2022. Pregnant women were classified as infected if they had a SARS CoV-2 positive RT-PCR or a positive rapid antigen test. An exploratory analysis of qualitative variables was conducted with calculation of absolute and relative frequencies and calculation of 95% confidence intervals. Survival functions were estimated by the Kaplan–Meier method, and the Cox proportional hazards model was employed to interpret the effects of SARS-CoV-2 infection on time to adverse maternal and perinatal outcomes, adjusted for vaccination, comorbidity, and gestational trimester.

Results

A total of 21% (249/1185) women were infected with SARS-CoV-2, with a median age of 26 (range: 16–47). Cesarean section deliveries were performed in 57% (135/237) SARS CoV-2+ participants vs. 43% (391/914) of uninfected participants, p < 0.001. Intensive care unit admission and/or death occurred in 68 of 1185 participants (5.7%), 44 of 249 participants (17.7%) infected with SARS CoV-2 vs. 24 of 936 uninfected participants (2.5%). All 21 participants who died were unvaccinated against COVID-19. Women infected with SARS-CoV-2 were at greater risk of adverse maternal outcomes (crude HR: 5.93, 95% CI: 3.58–9.84; adjusted HR: 5.47, 95% CI: 3.16–9.48) than uninfected pregnant women. SARS CoV-2 vertical transmission was observed in 6 of 169 (3.6%) tested neonates. Preterm deliveries occurred more frequently in patients testing positive for SARS-CoV-2 (30.7% vs. 23.6). In the survival analysis, no effect of SARS-CoV-2 infection was observed on prematurity (HR: 0.92, 95% CI: 0.68–1.23) and adverse perinatal outcomes, including fetal distress (HR: 1.29, 95% CI: 0.82–2.05), stillbirth (HR: 1.07, 95% CI: 0.48–2.38), and neonatal death (HR: 0.96, 95% CI: 0.35–2.67), even after adjusting for vaccination, comorbidity, gestational trimester, and periods of time.

Conclusion

The risk of maternal death due to COVID-19 highlights the need for adequate preventive measures, particularly vaccination, during the prenatal and postpartum periods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pregnancy Complications, InfectiousHumansFemalePregnancyBrazilAdultInfant, NewbornPregnancy OutcomeSARS-CoV-2Young AdultCohort StudiesAdolescentInfectious Disease Transmission, Vertical

Stichwörter der Autor:innen

COVID-19SARS-CoV-2adverse outcomesdeath maternalmortalityperinatal outcomespregnancypreterm birth

Autor:innen und Institutionen

  • Maternity Department, Adão Pereira Nunes Hospital, Duque de Caxias 25.211-970, Brazil.
  • Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro 21.040-360, Brazil.
  • Pediatric Infectious Diseases Division, David Geffen School of Medicine, University of California, Los Angeles, CA 90024, USA.

ORCID-Profile: Michelle Brendolin, Mayumi Duarte Wakimoto, Raquel de Vasconcellos Carvalhaes de Oliveira, Karin Nielsen-Saines, Patricia Brasil

Förderung

  • European Union
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Medical Research Council
  • National Council for Scientific and Technological Development
  • Simons Foundation
  • Carlos Chagas Foundation for the Advancement of Science of the State of Rio de Janeiro
  • Simons Foundation Autism Research Initiative
  • UK Medical Research Council

Zitieren

APA

Brendolin, M., Wakimoto, M. D., de Oliveira, R. V. C., Mageste, L. R., Nielsen-Saines, K., & Brasil, P. (2025). SARS-CoV-2 Infection and Adverse Maternal and Perinatal Outcomes: Time-to-Event Analysis of a Hospital-Based Cohort Study of Pregnant Women in Rio de Janeiro, Brazil. Viruses. https://doi.org/10.3390/v17020207

Vancouver

Brendolin M, Wakimoto MD, de Oliveira RVC, Mageste LR, Nielsen-Saines K, Brasil P. SARS-CoV-2 Infection and Adverse Maternal and Perinatal Outcomes: Time-to-Event Analysis of a Hospital-Based Cohort Study of Pregnant Women in Rio de Janeiro, Brazil. Viruses. 2025. doi:10.3390/v17020207

BibTeX
@article{Brendolin2025,
  author = {Brendolin, Michelle and Wakimoto, Mayumi Duarte and de Oliveira, Raquel de Vasconcellos Carvalhaes and Mageste, Larissa Rangel and Nielsen-Saines, Karin and Brasil, Patricia},
  title = {SARS-CoV-2 Infection and Adverse Maternal and Perinatal Outcomes: Time-to-Event Analysis of a Hospital-Based Cohort Study of Pregnant Women in Rio de Janeiro, Brazil},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17020207}
}
Kostenlos starten →